Skip to search formSkip to main contentSkip to account menu

LS 2616

Known as: LS-2616, LS2616 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The effects of the anti picornaviral drug WIN 54954 (5-(5-(2.6-dichloro-4-(4.5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-me thyl… 
Highly Cited
1993
Highly Cited
1993
Linomide (LS‐2616, quinoline‐3‐carboxamide) is a synthetic immunomodulator that stimulates natural killer cell activity and… 
1991
1991
The immunomodulator LS-2616 (Linomide) induces rejection of cyclosporine-protected rat cardiac allografts. The aim of this study… 
1989
1989
The quinoline-3-carboxamide, Linomide, has been shown to possess potent immunomodulatory activity. We have evaluated the effect… 
1989
1989
The effect of the quinoline-3-carboxamide LS-2616 (Linomide), given alone or together with cyclosporine, was studied in the first… 
1989
1989
Rat cardiac allografts protected with cyclosporin A are rejected in thepresence of LS-2616 (Linomide). 
Highly Cited
1986
Highly Cited
1986
Autoimmune (NZB X NZW) F1 female hybrid mice were treated with LS-2616, a recently developed substance with immunomodulating…